房颤射频消融术后口服抗心律失常药物选择  

Selection of oral antiarrhythmic drugs after radiofrequency ablation of atrial fibrillation

作　　者：随畅(综述) 魏子秀(审校)[2] SUI Chang;WEI Zixiu(Affiliated Hospital of Jining Medical University(School of Clinical Medicine),Jining 272013,China;Department of Cardidogy,Jining No.1 People′s Hospital,Jining 272011,China)

机构地区：[1]济宁医学院附属医院(临床医学院),济宁272013 [2]济宁市第一人民医院心内科,济宁272011

出　　处：《济宁医学院学报》2025年第1期84-87,共4页Journal of Jining Medical University

摘　　要：心房颤动(atrial fibrillation, AF)是临床实践中最常见的心律失常之一,与死亡、中风和外周栓塞的风险增加有关。目前研究表明,AF患者射频消融术(radiofrequency catheter ablation, RFCA)治疗维持窦性心律优于抗心律失常药物(antiarrhythmic drug, AAD),但RFCA后仍有较高的AF复发率。AAD的应用、RFCA技术的发展使心律控制治疗更安全、有效。临床研究提示患者RFCA后AAD的应用能更好地控制AF的复发,结合患者既往病史及其对心脏功能的影响,不同患者RFCA后AAD应用的选择至关重要。本文对AF患者RFCA后AAD的选择应用做一综述。Atrial fibrillation(AF)is one of the most common arrhythmias in clinical practice,associated with an increased risk of death,stroke,and peripheral embolism.It is confirmed that maintaining sinus rhythm could be benefit for the patients,and current studies have shown that radiofrequency catheter ablation(RFCA)is superior to antiarrhyth-mic drugs(AAD)in maintaining sinus rhythm for the AF patients.However,there is still a high recurrence rate of AF patients after receiving RFCA treatment.The application of AAD and the development of RFCA technology have made it safer and more effective in cardiac rhythm controlling.Clinical studies suggest that the AAD application after RFCA treat-ment could decrease recurrence rate for AF patients.Considering the past medical treatment patients received and impact on cardiac functions,It is crucial for partial patients to utilize the AAD treatment after RFCA.This article provides a review of the application of AAD in AF patients after RFCA.

关 键 词：心房颤动 射频消融 抗心律失常药物 疗效评价 

分 类 号：R541.75[医药卫生—心血管疾病]